All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec001}
============

Aging and stress are thought to enhance neurodegenerative disease risk through the accumulation of misfolded and aggregated proteins \[[@pgen.1008295.ref001]--[@pgen.1008295.ref003]\]. The lysosome is the key degradative organelle within the cell \[[@pgen.1008295.ref004]\], and therefore plays a pivotal role in the maintenance of protein homeostasis. It contains specialized enzymes, called cathepsins, which work optimally at the acidic pH in this compartment and have a crucial role in processing and degrading proteins \[[@pgen.1008295.ref005]\]. The transcription factor EB (TFEB) controls the expression of genes involved in lysosomal biogenesis and function \[[@pgen.1008295.ref006], [@pgen.1008295.ref007]\]. TFEB dysregulation has been associated with neurodegenerative disease \[[@pgen.1008295.ref008], [@pgen.1008295.ref009]\] and its overexpression may help to promote the clearance of protein aggregates \[[@pgen.1008295.ref010], [@pgen.1008295.ref011]\]. Although, genetic and functional studies have implicated lysosomal dysfunction in the pathogenesis of multiple neurodegenerative diseases \[[@pgen.1008295.ref012]--[@pgen.1008295.ref014]\], understanding of the molecular basis of this phenomenon remains incomplete.

Heterozygous progranulin *(PGRN)* loss-of-function mutations lead to autosomal dominant transmission of the neurodegenerative disorder frontotemporal lobar degeneration (FTLD) with TAR DNA binding protein 43 (TDP-43) inclusions \[[@pgen.1008295.ref015]--[@pgen.1008295.ref017]\]. The molecular function of the progranulin protein (PGRN) remained elusive until it was indelibly linked to lysosomal function by the finding that loss of both gene alleles results in the lysosomal storage disease, neuronal ceroid lipofuscinosis \[[@pgen.1008295.ref018]\]. Progranulin localizes to lysosomes \[[@pgen.1008295.ref019]--[@pgen.1008295.ref022]\] where it may act to promote lysosomal biogenesis and function \[[@pgen.1008295.ref020], [@pgen.1008295.ref023]--[@pgen.1008295.ref025]\].

The progranulin (PGRN) protein can be proteolytically cleaved to liberate multiple cysteine-rich "granulin" peptides \[[@pgen.1008295.ref026]\]. Granulins are highly conserved, disulfide-bonded miniproteins with unknown biological function \[[@pgen.1008295.ref027]--[@pgen.1008295.ref031]\]. Like progranulin, granulin peptides have been shown to localize to the endolysosomal compartment \[[@pgen.1008295.ref032]\], and can be generated through the action of cysteine proteases on progranulin \[[@pgen.1008295.ref032]--[@pgen.1008295.ref034]\]. Owing to the twelve cysteines and six disulfide bonds found in each cleaved granulin, these peptides adopt a stacked β-sheet configuration that is compact, structurally stable and potentially protease resistant \[[@pgen.1008295.ref035]\]. Several lines of evidence exist that cleaved granulin peptides oppose the function of the full-length protein. While progranulin has proliferative \[[@pgen.1008295.ref035], [@pgen.1008295.ref036]\] and anti-inflammatory \[[@pgen.1008295.ref037], [@pgen.1008295.ref038]\] properties, granulin peptides have been shown to inhibit cell growth \[[@pgen.1008295.ref035]\] and stimulate inflammation \[[@pgen.1008295.ref038]\]. In addition, we have previously demonstrated a role for *C*. *elegans* granulins in selectively promoting the accumulation of TDP-43, thereby exacerbating TDP-43 toxicity and potentially contributing to the pathogenesis of disease \[[@pgen.1008295.ref039]\]. However, the mechanism by which granulins exert this specific regulation on TDP-43 metabolism remains unknown. *C*. *elegans* provides many advantages as a model system to study granulin function, including conservation of the progranulin gene, and the many available molecular and cell biology techniques.

In this study, we further investigate the molecular mechanisms of *C*. *elegans* granulins on lysosomal function and protein homeostasis. We show that *C*. *elegans* granulins localize to the endolysosomal fraction. Granulin production increases with age and stress, and granulin expression reduces animal fitness by impairing lysosomal protease expression and activity. This prompts cells to activate a compensatory transcriptional program involving HLH-30/TFEB nuclear translocation and up-regulation of the transcription of HLH-30/TFEB-related genes. Overall, our findings highlight granulins as critical regulators of proteolytic lysosomal function and potential drivers of neurodegenerative disease pathogenesis.

Results {#sec002}
=======

*C*. *elegans* granulins impair organismal fitness and resistance to ER stress {#sec003}
------------------------------------------------------------------------------

We have previously shown that *C*. *elegans* progranulin (*pgrn-1)* null mutants exhibit enhanced resistance to endoplasmic reticulum (ER) unfolded protein stress \[[@pgen.1008295.ref040]\]. As a genetic null, *pgrn-1(-)* animals produce neither full-length progranulin nor cleaved granulins; therefore, absence of either the holoprotein or the cleavage fragments could be responsible for the ER stress resistance. Based on our earlier finding that granulins could exacerbate TDP-43 toxicity \[[@pgen.1008295.ref039]\], we hypothesized that the bioactive granulins were responsible for inhibiting ER stress resistance. Hence, to isolate granulin activity, we expressed individual *C*. *elegans* granulins 1, 2 and 3 at comparable levels in a *pgrn-1* null background \[[@pgen.1008295.ref039]\]. Granulin expression in a progranulin null background completely abolished the ER stress resistance phenotype ([Fig 1A](#pgen.1008295.g001){ref-type="fig"}). In contrast, animals over-expressing *C*. *elegans* full-length progranulin in a progranulin null background remained ER stress resistant ([Fig 1B](#pgen.1008295.g001){ref-type="fig"}). Over-expressed full-length progranulin was not cleaved under ER stress ([S1A--S1D Fig](#pgen.1008295.s001){ref-type="supplementary-material"}), and could promote ER stress resistance in the presence of granulin ([S1E Fig](#pgen.1008295.s001){ref-type="supplementary-material"}). Furthermore, transgenic expression of human tau protein and TDP-43 in a progranulin null background did not abrogate ER stress resistance ([S1F Fig](#pgen.1008295.s001){ref-type="supplementary-material"}). Taken together, these data suggest that it is the granulins, and not full-length progranulin, that specifically inhibit ER stress resistance.

![*C*. *elegans* granulins impair organismal fitness and resistance to ER stress.\
(**A**) Wild-type (N2) and *pgrn-1(-)* animals with and without granulin expression were subjected to ER stress with tunicamycin (5 μg / ml). The fraction developing to L4 stage was quantified (n = 50, 3 biological replicates). (**B**) Wild-type (N2) and *pgrn-1(-)* animals with and without *C*. *elegans* progranulin over-expression (OE) were subjected to ER stress with tunicamycin (5 μg / ml). The fraction developing to L4 stage was quantified (n = 50, 3 biological replicates). (**C**) Total worm lysates from synchronized day 1 adult granulin-expressing animals were immunoblotted with an anti-HSP-4/BiP antibody (3 biological replicates). Anti-actin was used as a loading control. (**D**) Wild-type and *pgrn-1(-)* animals with and without granulin expression were staged as embryos. Animals were scored for development to L4 stage (n = 50, 12 biological replicates). (**E**) Measurement of body length at day 1 adulthood (n = 12). (**F**) Measurement of short-term associative learning (three biological replicates). The glutamate receptor mutant *nmr-1(ak4)* was used as a positive control. Throughout, error bars show mean ± SEM, one or two-way ANOVA with post-hoc Tukey multiple comparisons test. Comparisons are to wild-type unless otherwise indicated (\**P*\<0.05, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001, ns = not significant, wt = wild-type).](pgen.1008295.g001){#pgen.1008295.g001}

Given that granulins impair ER stress resistance, we wondered if they might more broadly impact protein homeostasis. Thus, we measured endogenous levels of heat shock protein HSP-4, the nematode homolog of human BiP/Grp78 \[[@pgen.1008295.ref041]\]. HSP-4/BiP expression is upregulated during the unfolded protein response (UPR) \[[@pgen.1008295.ref042]\]. We found that granulin-expressing animals displayed a trend for increased basal expression of HSP-4/BiP on day 1 of adulthood, reaching significance in animals expressing granulin 2 and 3 ([Fig 1C](#pgen.1008295.g001){ref-type="fig"}). Therefore, in the absence of the progranulin holoprotein, granulin expression upregulates HSP-4 and this is indicative of UPR induction and perturbed protein homeostasis.

While working with the granulin-expressing lines, we noted a decrease in overall animal fitness attributable to the granulins. Granulin production significantly reduced animal viability by lowering the number of eggs that hatched and slowing the development of animals to maturity ([Fig 1D](#pgen.1008295.g001){ref-type="fig"}). Granulin-expressing animals that did reach adulthood were smaller in size ([Fig 1E](#pgen.1008295.g001){ref-type="fig"}). Short-term associative learning can be assayed in *C*. *elegans* using a positive olfactory learning paradigm \[[@pgen.1008295.ref043], [@pgen.1008295.ref044]\]. When granulin-expressing animals were tested in this assay they underperformed compared to controls ([Fig 1F](#pgen.1008295.g001){ref-type="fig"}), suggesting that granulin expression may result in neuronal dysfunction. These data, coupled with previous work by others on the function of progranulin \[[@pgen.1008295.ref035]--[@pgen.1008295.ref038]\], suggest that granulins impair animal fitness, resistance to stress and neuronal function, while progranulin promotes these qualities.

Granulins localize to the endolysosomal compartment {#sec004}
---------------------------------------------------

To establish the trafficking and localization of granulin peptides within a whole organism, we utilized microscopy and biochemistry techniques. First, we determined the sub-cellular localization of full-length progranulin using a translational progranulin reporter, PGRN-1::RFP, and organelle-specific markers. As expected, in cells that secrete progranulin, such as the intestine, the reporter co-localized with both a Golgi marker, mannosidase II ([Fig 2A](#pgen.1008295.g002){ref-type="fig"}), and a lysosomal marker, lysosomal-associated membrane protein 1 (LMP-1) ([Fig 2B](#pgen.1008295.g002){ref-type="fig"}). However, in coelomocytes, a cell type that takes up but does not produce progranulin \[[@pgen.1008295.ref045]\], the progranulin reporter was only seen in the endolysosomal compartment ([Fig 2C--2E](#pgen.1008295.g002){ref-type="fig"}), suggesting that extracellular progranulin is transported through endosomes to reach the lysosome.

![*C*. *elegans* progranulin and granulins localize to the endolysosomal compartment.\
A translational PGRN-1::RFP reporter (red) co-localizes with (**A**) Golgi (mannosidase II::GFP) and (**B**) lysosomes (LMP-1::GFP) in the intestine of L1 stage larvae (anterior to the left). In scavenging coelomocytes, PGRN-1::RFP does not co-localize with (**C**) Golgi (mannosidase II::GFP), but does co-localize with (**D**) early, late and recycling endosomes (RME-8::GFP) and (**E**) lysosomes (LMP-1::GFP) (n = 8 animals per GFP marker). Dashed white lines mark the outline of each coelomocyte cell and white boxes show zoomed insets in Fig 2A-B, scale bar = 5 μm. Shown are representative images from confocal microscopy z-stack sections taken at 0.7 μm. (**F-I**) Subcellular fractionation of *pgrn-1(-)* animals (**F**), and *pgrn-1(-)* animals with expression of (**G**) granulin 1, (**H**) granulin 2, and (**I**) granulin 3. Whole lysate (WL), cytosol (C), lysosome (L) and endoplasmic reticulum (ER) fractions (10 μg total protein) were immunoblotted with anti-FLAG and anti-LMP-1 antibodies.](pgen.1008295.g002){#pgen.1008295.g002}

Having established that progranulin can be trafficked from one tissue type to another, we next sought to better understand the subcellular localization of granulin peptides. To do so, we developed a protocol for subcellular fractionation of *C*. *elegans*. The purity of cytosolic, ER and endolysosomal fractions was confirmed with established markers ([S2 Fig](#pgen.1008295.s002){ref-type="supplementary-material"}). Individual granulins that were transgenically expressed also demonstrated lysosomal localization ([Fig 2F--2I](#pgen.1008295.g002){ref-type="fig"}). Therefore, *C*. *elegans* progranulin and granulins localize to the endolysosomal compartment.

Granulins are produced in an age- and stress-dependent manner and disrupt lysosomal morphology {#sec005}
----------------------------------------------------------------------------------------------

In *C*. *elegans* and mammals, progranulin production increases with age \[[@pgen.1008295.ref045], [@pgen.1008295.ref046]\] and injury \[[@pgen.1008295.ref047], [@pgen.1008295.ref048]\]. However, the degree to which granulin peptides are liberated has not been measured. We first asked if progranulin cleavage into granulins increases with age. Using our PGRN-1::RFP translational reporter, we found that granulin production does indeed increase in an age-dependent fashion ([Fig 3A](#pgen.1008295.g003){ref-type="fig"} and [S3A and S3B Fig](#pgen.1008295.s003){ref-type="supplementary-material"}), suggesting that either an increase in expression and cleavage of progranulin, and/or an age-associated decline in granulin turnover, contributes to granulin accumulation. Granulin cleavage also increased in response to certain physiological stressors such as starvation ([Fig 3B](#pgen.1008295.g003){ref-type="fig"} and [S3C and S3D Fig](#pgen.1008295.s003){ref-type="supplementary-material"}). Thus, age and stressful stimuli, such as starvation, appear to promote the cleavage of full-length progranulin into granulins.

![Granulins are produced in an age- and stress-dependent manner and disrupt lysosomal morphology.\
(**A-B**) Western blot of *C*. *elegans* PGRN-1::RFP lysates with (**A**) aging and (**B**) starvation. Immunoblotting was performed with an anti-granulin 3 antibody. NS = non-specific band. The most prominent cleavage product at \~30kDa was recognized by both granulin 3 and RFP antibodies (see [S3E Fig](#pgen.1008295.s003){ref-type="supplementary-material"}). (**C**) Subcellular fractionation of *pgrn-1(-)*; PGRN::RFP animals. Whole lysate (WL), cytosol (C), lysosome (L) and endoplasmic reticulum (ER) fractions from fed and starved (70 hours off-food) animals were immunoblotted with anti-granulin 3 and anti-LMP-1 antibodies. The same progranulin full-length and cleavage bands were also identified with an anti-RFP antibody ([S3F Fig](#pgen.1008295.s003){ref-type="supplementary-material"}). Well-fed *pgrn-1(-)* animals are shown as a control for non-specific bands (NS). (**D-G**) Representative light and fluorescent confocal images of anterior coelomocyte cells expressing LMP-1::GFP in (**D**) wild-type, (**E**) *pgrn-1(-)*, (**F**) *pgrn-1(-)*; granulin 2(+) and (**G**) *pgrn-1(-)*; granulin 3(+) animals. Animals were imaged at L4 stage. Scale bars are 10 μm in the wild-type panel and 5 μm in remaining panels. Dashed white lines mark the outline of each coelomocyte cell. Open white arrow heads indicate spherical lysosomes and closed white arrow heads indicate tubular extensions (number of animals with tubular extensions: wt: 2/22, *pgrn-1(-)*: 10/21, *pgrn-1(-)*; granulin 2(+): 7/25, *pgrn-1(-)*; granulin 3(+); 13/24). (**H**) Lysosomal diameter measurements from anterior coelomocyte cells of L4 stage animals (n = 60). Error bars show mean ± SEM, one-way ANOVA with post-hoc Tukey multiple comparisons test (mean values (μm): wt: 1.57 ± 0.04, *pgrn-1(-)*: 1.37 ± 0.05, *pgrn-1(-)*; granulin 2(+): 1.47 ± 0.05, *pgrn-1(-)*; granulin 3(+): 1.16 ± 0.05). Comparisons are to wild-type unless otherwise indicated (\**P*\<0.05, \*\**P*\<0.01, \*\*\*\**P*\<0.0001, wt = wild-type).](pgen.1008295.g003){#pgen.1008295.g003}

In order to determine the subcellular compartment in which cleaved granulin peptides are produced, we performed fractionation of fed or starved animals expressing the PGRN-1::RFP reporter. In fed animals, full-length progranulin was enriched in the endolysosomal fraction with very little lower molecular weight granulin observed in any fraction ([Fig 3C](#pgen.1008295.g003){ref-type="fig"}). Upon starvation, the cleaved granulins increased primarily in the endolysosomal fraction, confirming that the majority of the age and stress-induced granulins are, in fact, endolysosomal ([Fig 3C](#pgen.1008295.g003){ref-type="fig"}). Therefore, granulin peptides are produced *in vivo* in the endolysosomal compartment in a stress-responsive manner.

Given that granulins impair organismal fitness, localize to the endolysosomal fraction and impair stress resistance, we next investigated their impact on lysosomal morphology. In *C*. *elegans*, coelomocytes scavenge and detoxify the pseudocoelomic cavity and therefore have a well-developed endo-lysosomal system \[[@pgen.1008295.ref049]\]. Although we could not image coelomocyte lysosomes in granulin 1-expressing animals due to the presence of a GFP co-expression marker, we found that both loss of progranulin and expression of granulins 2 and 3 grossly deformed these organelles ([Fig 3D--3G](#pgen.1008295.g003){ref-type="fig"}). Lysosomes lost their spherical shape, more frequently exhibited membrane protrusions and tubular extensions ([Fig 3D--3G](#pgen.1008295.g003){ref-type="fig"}), and became smaller in size, reaching significance for *pgrn-1(-)* animals and *pgrn-1(-)*; granulin 3(+) animals ([Fig 3H](#pgen.1008295.g003){ref-type="fig"}). Together, these data suggest that granulin peptides accumulate in endolysosomes with age and starvation, where they, as well as loss of progranulin, may disrupt lysosomal morphology.

Granulins impair lysosomal protease activity {#sec006}
--------------------------------------------

As we observed that expressed granulins disrupt lysosomal morphology, we next assessed their effect on lysosomal function by measuring the expression level and enzymatic activity of lysosomal proteases in lysates from granulin-expressing *C*. *elegans*. Granulin expression resulted in decreased protein levels of ASP-3, the nematode ortholog of mammalian cathepsin D (CTSD), reaching significance in granulin 2-expressing animals ([Fig 4A](#pgen.1008295.g004){ref-type="fig"}). Expression of all granulins significantly reduced CPL-1 expression, the nematode ortholog of mammalian cathepsin L (CTSL) ([Fig 4B](#pgen.1008295.g004){ref-type="fig"}). This decrease in protease expression correlated with a decrease in protease activity ([Fig 4C and 4D](#pgen.1008295.g004){ref-type="fig"}), reaching significance in granulin 2 and 3-expressing animals for ASP-3 activity and granulin 1 and 2-expressing animals for CPR/CPL-1 activity. Overall, our data suggest that granulin peptides disrupt *C*. *elegans* lysosomal protease activity *in vivo*.

![Granulin peptides impair lysosomal protease expression and activity.\
Total worm lysates from synchronized day 1 adult granulin-expressing animals were immunoblotted with antibodies recognizing (**A**) the aspartyl protease ASP-3/CTSD and (**B**) the cysteine protease CPL-1/CTSL. An anti-actin antibody was used as a loading control. Representative Western blots are shown and data were quantified from 3 independent biological repeats. Enzymatic activity measured in total worm lysates for (**C**) ASP-3/CTSD and (**D**) cysteine protease activity for CPR/CTSB and CPL-1/CTSL. CTSB/Li, cathepsin B and L inhibitor. Data were quantified from 3 independent biological repeats. Throughout, values shown are mean ± SEM, one-way ANOVA with Tukey multiple comparisons test, \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001). Animals lacking *asp-3* continue to have significant protease activity, likely due to other endogenous aspartyl proteases that are inhibited by the pan-aspartyl protease inhibitor, Pepstatin A.](pgen.1008295.g004){#pgen.1008295.g004}

*C*. *elegans* granulin domains display distinct electrostatic and hydrophobicity profiles that may contribute to functional specificity {#sec007}
----------------------------------------------------------------------------------------------------------------------------------------

As we observed differences between the three granulins in terms of the magnitude of their phenotypic effects within assays, we sought to determine whether these differences might be explained by variations in their amino acid sequence and physicochemical properties. *C*. *elegans* granulins 1, 2 and 3 share less than 50% sequence identity among themselves ([Fig 5A](#pgen.1008295.g005){ref-type="fig"}), and less than 40% when excluding the highly conserved network of disulfide bonds. Electrostatic analysis ([Fig 5B](#pgen.1008295.g005){ref-type="fig"}) shows that granulin 3, located at the C-terminus of *C*. *elegans* PGRN-1, is positively charged at neutral pH, while granulin 1, the N-terminal granulin domain, remains negatively charged at all analyzed pH values (pH = 4 to 8). The central granulin 2 domain has little to no overall net peptide charge at neutral pH. A further comparison of granulin hydrophobicity ([Fig 5C](#pgen.1008295.g005){ref-type="fig"}) shows that the central region of granulin 2 (residues 202 to 221) and granulin 3 (residues 309 to 326) is predominantly hydrophobic, as measured by Kyte and Doolittle (K&D) hydrophobicity scores greater than zero. In contrast, the K&D score for the corresponding region of granulin 1 (res. 120 to 139) is slightly negative. While the functions of the individual *C*. *elegans* granulin domains remain to be further elucidated, these observed differences might suggest that each domain participates in unique protein-protein interactions (PPIs), and thus differing roles in the endolysosomal system.

![Computational analysis of granulin sequence across species highlights their distinct electrostatic and hydrophobicity profiles.\
(**A**) Amino acid multiple sequence alignment for *C*. *elegans*, *Homo sapiens*, *Mus musculus and Danio rerio* (PGRNb) granulin domains using the MAFFT (Multiple Alignment using Fast Fourier Transform) server. Residues matching the granulin consensus sequence are highlighted in cyan. The identity score (%) between all granulin domains and *C*. *elegans* granulins 1, 2 and 3 from pairwise sequence alignment using the EMBOSS Needle server is indicated on the right. The granulin domains of different species sharing the highest identity score to *C*. *elegans* granulins 1, 2 and 3 are highlighted in square boxes. (**B**) pH-dependent electrostatic charge scale calculated by propKa 3.1. A 3-color scale is used for the granulin domains, colored from red (negative) to blue (positive) using a percentile scale. (**C**) Kyte and Doolittle (K&D) hydrophobicity scores for granulin domains of *C*. *elegans*. The central regions of granulins 2 and 3 are highlighted with circles since most of these residues have positive K&D scores, which is suggestive of a potential hydrophobic patch.](pgen.1008295.g005){#pgen.1008295.g005}

We further compared the *C*. *elegans* granulin sequences with those of different species, including *Homo sapiens (H*. *sapiens)*, *Mus musculus (M*. *musculus)* and *Danio rerio* (*D*. *rerio)* ([Fig 5A](#pgen.1008295.g005){ref-type="fig"}). We found that *C*. *elegans* granulins share higher identity scores to certain granulins from other species than among themselves. Similar to *C*. *elegans* granulins, differences in pH-dependent electrostatics ([Fig 5B](#pgen.1008295.g005){ref-type="fig"}) were noticeable for all species studied, with a recurring trend for the C-terminal granulin domains being the most positively charged. The low sequence identity and distinct physicochemical properties among the granulin domains were also observed for *H*. *sapiens*, *M*. *musculus* and *D*. *rerio*, contrasting with the highly conserved network of disulfide bonds. Taken together, these data highlight the importance of the amino acid residues situated outside of the well-conserved granulin sequence consensus for contributing to the charge and hydrophobicity profiles of each granulin domain. These may drive unique recognition patterns for PPIs that may ultimately be relevant in a disease context.

Granulins activate the lysosomal CLEAR response and induce nuclear localization of HLH-30/TFEB {#sec008}
----------------------------------------------------------------------------------------------

To determine if granulin-induced disruption of lysosomal morphology and function promoted a transcriptional response, we performed RNA-seq profiling of wild-type, *pgrn-1(-)* and granulin-expressing animals ([S1](#pgen.1008295.s007){ref-type="supplementary-material"}--[S5](#pgen.1008295.s011){ref-type="supplementary-material"} Tables). Visual inspection of the RNA sequencing reads confirmed a high and comparable expression of granulin 1, 2 and 3 transgenes, as well as a read drop-out in progranulin null animals ([S4A Fig](#pgen.1008295.s004){ref-type="supplementary-material"}). Wild-type animals had a low but detectable expression of endogenous progranulin transcript ([S4A Fig](#pgen.1008295.s004){ref-type="supplementary-material"}). We first compared *pgrn-1(-)* or *pgrn-1(-)*; granulin animals to wild-type animals. Compared to wildtype, a total of 7084 differentially expressed genes (DEGs) were identified across all strains ([Fig 6A](#pgen.1008295.g006){ref-type="fig"} and [S4B Fig](#pgen.1008295.s004){ref-type="supplementary-material"}). The majority of DEGs identified for *pgrn-1(-)* animals were down-regulated compared to wild-type animals. These DEGs were enriched for GO terms associated with growth, development, cation and sugar binding ([S4C and S4D Fig](#pgen.1008295.s004){ref-type="supplementary-material"}). In contrast, the majority of DEGs for granulin-expressing animals were up-regulated compared to both wild-type and *pgrn-1(-)* animals ([Fig 6A](#pgen.1008295.g006){ref-type="fig"} and [S4B Fig](#pgen.1008295.s004){ref-type="supplementary-material"}). GO term analysis for DEGs in granulin-expressing animals showed a shared enrichment in genes associated with lysosomal function, including protein metabolic process and hydrolase activity acting on ester bonds ([S4E--S4K](#pgen.1008295.s004){ref-type="supplementary-material"} and [S5](#pgen.1008295.s005){ref-type="supplementary-material"} Figs). Expression of granulin 2 resulted in the highest number of DEGs compared to both wild-type and *pgrn-1(-)* animals, followed by granulin 3 and then granulin 1 ([Fig 6A](#pgen.1008295.g006){ref-type="fig"} and [S4B Fig](#pgen.1008295.s004){ref-type="supplementary-material"}). The observed overlap in enriched GO terms on granulin 2 and 3 expression further suggests similarities between these two granulins compared to granulin 1, and also reflects the phenotype severity observed in development and behavioral assays. Interestingly, the upregulated DEGs identified in *pgrn-1(-)*; granulin 3(+) animals were significantly enriched for genes whose promoters contained the putative TFEB binding site E-box sequence 5'-CACGTG-3' (*P* = 0.011). This trend was also observed in the upregulated DEGs for *pgrn-1(-)*; granulin 1(+) (*P* = 0.149) and *pgrn-1(-)*; granulin 2(+) (*P* = 0.097) but did not reach statistical significance. TFEB is the master lysosomal transcription factor that regulates lysosomal biogenesis and autophagy \[[@pgen.1008295.ref006], [@pgen.1008295.ref007]\], and the *C*. *elegans* TFEB is HLH-30 \[[@pgen.1008295.ref050]\].

![Granulins activate the lysosomal CLEAR response and induce nuclear localization of HLH-30/TFEB.\
(**A**) Heat map showing the fold-changes of gene expression in comparisons of day 1 adult animals as indicated. Data from four independent biological replicates are shown (except for granulin 1 where one sample was excluded as a quality control outlier). Significance cut-off was a false discovery rate (FDR) of *P*\<0.05 (up-regulated = red, down-regulated = green). Number of HLH-30/TFEB binding sites identified/total number of DEGs: *pgrn-1(-)* vs wt: 67/233, *pgrn-1(-)*; granulin 1(+) vs wt: 18/179, *pgrn-1(-)*; granulin 2(+) vs wt: 408/4050, *pgrn-1(-)*; granulin 3(+) vs wt: 1136/2560. See [S1](#pgen.1008295.s007){ref-type="supplementary-material"}--[S5](#pgen.1008295.s011){ref-type="supplementary-material"} Tables for the complete gene lists. (**B**) Representative images of wild-type, *pgrn-1(-)* and *pgrn-1(-); granulin 3(+)* animals expressing HLH-30::GFP (scale bar = 200 μm). (**C**) Percentage of animals with nuclear localized HLH-30::GFP (n = 120 animals from 3 biological replicates). Wild-type, *pgrn-1(-)* and granulin-expressing animals with and without *hlh-30* expression were staged as embryos, and animals were scored for (**D**) development to gravid adult (n = 50, 3 biological replicates), and (**E**) the number of larvae arresting at L1 and L2 stage (n = 50, 3 biological replicates). Throughout, values shown are mean ± SEM, one-way ANOVA and Tukey multiple comparisons test. Comparisons are to wild-type unless otherwise indicated (\**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001, ns = not significant). The \~20% larval arrest observed in the *pgrn-1(-)* strains with wild-type *hlh-30* reach significance when compared pairwise with wildtype using a Student's t-test (\**P*\<0.05). (**F**) Genetic model for progranulin and granulin function in lysosomal function, protein homeostasis and stress resistance.](pgen.1008295.g006){#pgen.1008295.g006}

In response to starvation, stressful stimuli and aging, HLH-30/TFEB translocates from the cytosol to the nucleus to activate its transcriptional targets \[[@pgen.1008295.ref006], [@pgen.1008295.ref007], [@pgen.1008295.ref050], [@pgen.1008295.ref051]\]. This program, known as the Coordinated Lysosomal Expression and Regulation (CLEAR) response induces expression of genes involved in lysosomal function and autophagy, including progranulin. We assessed HLH-30/TFEB cytoplasmic versus nuclear localization in control, *pgrn-1(-)* and granulin expressing animals. Granulin expression promoted nuclear localization of HLH-30/TFEB, reaching significance in granulin 3-expressing animals ([Fig 6B and 6C](#pgen.1008295.g006){ref-type="fig"}). This effect was not seen in *pgrn-1(-)* animals where a much lower number of DEGs were identified, and was also not observed in *pgrn-1(-)* animals expressing human tau or TDP-43 protein ([S6A Fig](#pgen.1008295.s006){ref-type="supplementary-material"}). These results suggest that the disruption of lysosomal morphology and protein homeostasis seen in granulin-expressing animals leads to a specific compensatory translocation of HLH-30/TFEB from the cytosol to the nucleus.

When granulin-expressing animals were crossed into a wildtype background, the presence of wildtype progranulin partially mitigated the negative effects of granulin-expression on development ([S6B Fig](#pgen.1008295.s006){ref-type="supplementary-material"}), lysosome morphology ([S6C and S6D Fig](#pgen.1008295.s006){ref-type="supplementary-material"}) and HLH-30/TFEB localization ([S6E Fig](#pgen.1008295.s006){ref-type="supplementary-material"}). Interestingly, granulin-expression in a wildtype background resulted in higher ER stress sensitivity than granulin-expression in a progranulin null background ([S6F Fig](#pgen.1008295.s006){ref-type="supplementary-material"}). We speculate that ER stress may promote the cleavage of endogenous PGRN, resulting in even higher levels of cleaved granulins (endogenous *and* transgenic granulins) and enhanced ER stress sensitivity. These data further suggest a reciprocal relationship between full-length progranulin and cleaved granulins, and highlights that their relative levels may be important for normal animal development and fitness.

To determine if the upregulation of TFEB target genes was a compensatory transcriptional response in granulin-expressing animals, we crossed these animals into an *hlh-30(-)* null background. When lacking *hlh-30*, granulin-expressing animals had further impairments in overall fitness, with fewer growing to adulthood ([Fig 6D](#pgen.1008295.g006){ref-type="fig"}) and more arresting at early larval stages ([Fig 6E](#pgen.1008295.g006){ref-type="fig"}). Together, these data demonstrate that granulin expression, even in the absence of stress or starvation, is sufficient to activate a compensatory CLEAR response and induce expression of genes containing TFEB binding sites. Overall, the ability of granulins to 1) impair a proteotoxic stress response, 2) disrupt lysosomal morphology, 3) direct TFEB to the nucleus and 4) induce a CLEAR response indicates that granulin-dependent impairment of lysosomal function negatively impacts cellular protein homeostasis ([Fig 6F](#pgen.1008295.g006){ref-type="fig"}).

Discussion {#sec009}
==========

We have previously shown in *C*. *elegans* that expression of granulin peptides enhances TDP-43 toxicity and prevents its degradation \[[@pgen.1008295.ref039]\]. In this study, we sought to understand the mechanism by which granulins exert their effects and determine if they more broadly impacted protein homeostasis. We found that granulins are produced in an age and stress-dependent manner, and consequently impair lysosomal protease expression and activity. Their expression negatively impacts cellular protein homeostasis and drives a compensatory lysosomal stress response in an attempt to up-regulate HLH-30/TFEB-regulated genes. These effects manifest as an overall decrease in animal fitness.

This study contributes a new dimension to our understanding of the regulation of lysosomal proteostasis via the identification of *C*. *elegans* granulins as age and stress-produced peptides that impair overall animal fitness by reducing lysosomal function. *C*. *elegans* granulins, similar to the human peptides, localize to the endolysosomal compartment \[[@pgen.1008295.ref032]\]. Granulins are composed of evolutionarily conserved stacked beta hairpins stabilized by disulfide bonds, which are often found in natural protease inhibitors \[[@pgen.1008295.ref052]\]. This highly compact and stable structure is thought to confer resistance to denaturation and protection against proteolytic cleavage in the lysosomal environment \[[@pgen.1008295.ref053]\]. Indeed, a role for granulins in regulating protease maturation has previously been demonstrated in plant cysteine proteases that incorporate a granulin domain C-terminal to the catalytic domain, such as RD21 in *A*. *thaliana* \[[@pgen.1008295.ref054]\]. In further support of granulins as regulators of protease activity, homozygous progranulin mutation carriers develop a progressive myoclonic epilepsy syndrome that phenocopies loss of function mutations in another lysosomal protease inhibitor, cystatin B \[[@pgen.1008295.ref018], [@pgen.1008295.ref055]\]. Recent studies have shown that human full-length progranulin and individual granulin domains may physically interact with CTSD and stimulate the enzymatic activity of the protease \[[@pgen.1008295.ref025], [@pgen.1008295.ref056]--[@pgen.1008295.ref058]\]. However, in the absence of full-length protein, *C*. *elegans* granulins promote a distinct phenotype of impaired resistance to ER stress, delayed growth, decreased CTSD and CTSB/L activity and activation of the CLEAR transcriptional program.

Granulins likely play a *normal physiological role* in regulating protease expression and activity. Given their ability to promote the CLEAR program, granulins may serve as a signal for stress or impaired health that requires regulated checks on protease activity, perhaps to limit inflammation. This would be consistent with the role of progranulin in complement-mediated synaptic pruning by microglia \[[@pgen.1008295.ref059]\]. We speculate that under conditions of progranulin haploinsufficiency, the normal balance between progranulin and granulins becomes skewed towards excessive granulins. In excess, the inhibitory effect of granulins upon protease activity impairs the function of lysosomes; with age, the natural compensatory mechanisms such as the CLEAR program become overwhelmed, resulting in cellular dysfunction. When this occurs in neurons and/or support cells such as microglia, the end result may be neurodegeneration. Because granulins increase with age, it remains possible that accumulation of granulins directly contribute to the proteostatic pressures associated with increasing age. Comprehensive measures of progranulin-to-granulin ratios with age and in progranulin mutation carriers are needed.

The lentiviral delivery of progranulin to degenerating brain regions protects against neurotoxicity and cognitive defects in mouse models of Parkinson's disease \[[@pgen.1008295.ref060]\] and Alzheimer's disease \[[@pgen.1008295.ref061]\]. As such, efforts to increase progranulin production in patients are underway \[[@pgen.1008295.ref062]--[@pgen.1008295.ref065]\]. However, a more recent study has suggested that progranulin delivery to brain promotes in T-cell infiltration and neuronal and glial degeneration \[[@pgen.1008295.ref066]\]. Progranulin cleavage and granulin levels were not measured in these studies, and may account for differences in the observed results.

Progranulin is a highly conserved protein \[[@pgen.1008295.ref027], [@pgen.1008295.ref029], [@pgen.1008295.ref030]\]. The number of granulin domains has increased through phylogeny from one in *Dictyostelium discoideum* and plants, three in nematodes to seven-and-a-half in humans \[[@pgen.1008295.ref029], [@pgen.1008295.ref054]\]. It is intriguing to speculate that this expansion in cleavage fragments could lead to regulation of additional proteases. In support of this, we find that the amino acid residues situated outside of the well-conserved granulin sequence consensus contribute to distinct charge and hydrophobic profiles for each granulin domain. These unique characteristics may be important for driving specific protein-protein interactions and thus different roles in the cellular environment. Indeed, the distinct effects of granulin 2 and 3 on protein homeostasis, lysosomal function and TDP-43 toxicity \[[@pgen.1008295.ref039]\], as compared to granulin 1, may suggest functional differences between granulins.

Our results establish age-regulated granulins as modulators of lysosomal function, and suggest that a *toxic gain of granulin function*, rather than or in addition to simply loss of full-length progranulin, may contribute to FTLD disease pathogenesis. This could explain why progranulin loss-of-function mutations are transmitted in an autosomal dominant fashion. The presence of granulins only in the haploinsufficiency state could explain why TDP-43 pathology is not seen in the null state \[[@pgen.1008295.ref018]\]. Several lysosomal proteases that cleave progranulin have recently been identified \[[@pgen.1008295.ref032]--[@pgen.1008295.ref034]\], although how those proteases decide when and where to cleave progranulin remains unknown. This study prompts several important follow up questions regarding the rate and order in which granulins are liberated from progranulin, how pH changes impact the predicted association of granulins with lysosomal proteases and whether increased granulin impact other neurodegenerative disorders such as Alzheimer's disease. The current study also has implications for therapeutic progranulin repletion efforts, as care should be taken to determine whether replacement progranulin is processed into granulins. Finally, our findings suggest that in addition to progranulin repletion, prevention of progranulin cleavage into granulins could represent a rational therapeutic target in neurodegeneration.

Materials and methods {#sec010}
=====================

Strains {#sec011}
-------

*C*. *elegans* strains were cultured at 20 °C according to standard procedures \[[@pgen.1008295.ref067]\]. Some strains were provided by the Mitani Laboratory (National Bioresource Project, Japan) at the Tokyo Women's Medical University and the Caenorhabditis Genetics Center (CGC) at the University of Minnesota. Strain descriptions are at [www.wormbase.org](http://www.wormbase.org). The N2E control strain was used as the wild-type strain. The *pgrn-1(tm985)* strain has a 347 bp deletion in the *pgrn-1* gene resulting in a null allele \[[@pgen.1008295.ref045]\]. The following *C*. *elegans* strains were used in this study:

[CF3050]{.ul} *pgrn-1(tm985) I*

[AWK33]{.ul} *pgrn-1(tm985) I; rocIs1\[Ppgrn-1+SignalSequence*::*granulin1*::*FLAG*::*polycistronic mCherry + Punc-122*::*GFP\]*

[AWK43]{.ul} *pgrn-1(tm985) I*; *rocEx14\[Ppgrn-1+SignalSequence*::*granulin2*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK107]{.ul} *pgrn-1(tm985) I*; *rocIs5\[Ppgrn-1+SignalSequence*::*granulin3*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK308]{.ul} N2E*; rocIs1\[Ppgrn-1+SignalSequence*::*granulin1*::*FLAG*::*polycistronic mCherry + Punc-122*::*GFP\]*

[AWK309]{.ul} N2E; *rocEx14\[Ppgrn-1+SignalSequence*::*granulin2*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK310]{.ul} N2E; *rocIs5\[Ppgrn-1+SignalSequence*::*granulin3*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK459]{.ul} *pgrn-1(tm985) I; muIs216\[Paex-3*::*huMAPT 4R1N +Pmyo-3*::*RFP\]*

[CF3588]{.ul} *pgrn-1(tm985) I; muIs206\[Pegl-3*::*TDP-43*::*GFP\]*

[AWK524]{.ul} *pgrn-1(tm985) I; muIs189\[Ppgrn-1*::*pgrn-1*::*polycishronic mCherry +Podr-1*::*CFP\]*

[AWK466]{.ul} *pgrn-1(tm985) I; muIs189\[Ppgrn-1*::*pgrn-1*::*polycishronic mCherry +Podr-1*::*CFP\]*; *rocEx14\[Ppgrn-1+SignalSequence*::*granulin2*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[CF3778]{.ul} *pgrn-1(tm985) I; muIs213\[Ppgrn-1*::*pgrn-1*::*RFP\]*

[AWK181]{.ul} *pgrn-1(tm985) I; unc-119(ed3)III; pwIs503\[vha6p*::*mans*::*GFP + Cb unc-119(+)\]; muIs213\[Ppgrn-1*::*pgrn-1*::*RFP\]*

[AWK360]{.ul} *pgrn-1 (tm985) I; unc-119(ed3) III; pwIs50\[Plmp-1*::*lmp-1*::*GFP + Cbr-unc-119(+)\]; muIs213\[Ppgrn-1*::*pgrn-1*::*RFP\]*

[AWK395]{.ul} *pgrn-1 (tm985) I; unc-119(ed3) III; cdIs54\[pcc1*::*MANS*::*GFP + unc-119(+) + myo-2*::*GFP\]; muIs213\[Ppgrn-1*::*pgrn-1*::*RFP\]*

[AWK374]{.ul} *pgrn-1 (tm985) I; bIs34\[rme-8*::*GFP + rol-6(su1006)\]; muIs213\[Ppgrn-1*::*pgrn-1*::*RFP\]*

[MAH235]{.ul} *sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]*

[AWK403]{.ul} *pgrn-1(tm985) I; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]*

[AWK404]{.ul} *pgrn-1(tm985) I; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]; rocIs1\[Ppgrn-1+SS*::*granulin1*::*FLAG*::*polycistronic mCherry\]*

[AWK405]{.ul} *pgrn-1(tm985) I; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]; rocEx14\[Ppgrn-1+SS*::*granulin2*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK406]{.ul} *pgrn-1(tm985) I; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]; rocIs5\[Ppgrn-1+SS*::*granulin3*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK467]{.ul} N2E*; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]; rocIs1\[Ppgrn-1+SS*::*granulin1*::*FLAG*::*polycistronic mCherry\]*

[AWK469]{.ul} N2E*; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]; rocEx14\[Ppgrn-1+SS*::*granulin2*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK471]{.ul} N2E*; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]; rocIs5\[Ppgrn-1+SS*::*granulin3*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK546]{.ul} *pgrn-1(tm985) I; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]; muIs216\[Paex-3*::*huMAPT 4R1N +Pmyo-3*::*RFP\]*

[AWK547]{.ul} *pgrn-1(tm985) I; sqIs19\[Phlh-30*::*hlh-30*::*gfp + rol-6(su1006)\]; muIs206\[Pegl-3*::*TDP-43*::*GFP\]*

[JIN1375]{.ul} *hlh-30(tm1978) IV*

[AWK514]{.ul} *pgrn-1 (tm985) I; hlh-30(tm1978) IV*

[AWK516]{.ul} *pgrn-1 (tm985) I; hlh-30(tm1978) IV; rocIs1\[Ppgrn-1+SS*::*granulin1*::*FLAG*::*polycis mCherry\]*

[AWK518]{.ul} *pgrn-1 (tm985) I; hlh-30(tm1978) IV; rocEx14 \[Ppgrn-1+SS*::*granulin2*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK519]{.ul} *pgrn-1 (tm985) I; hlh-30(tm1978) IV; rocIs5 \[Ppgrn-1+SS*::*granulin3*::*FLAG*::*polycistronic mCherry + Pmyo-2*::*GFP\]*

[AWK521]{.ul} *pgrn-1 (tm985) I; hlh-30(tm1978) IV; muIs189\[Ppgrn-1*::*pgrn-1*::*polycistronic mCherry +Podr-1*::*CFP\]*

[AWK296]{.ul} N2E; *Ex\[Pced-1*::*asp-3*::*mrfp + pRF4(rol-6)\]; unc-119(ed3) III; pwIs50\[Plmp-1*::*lmp-1*::*GFP + Cbr-unc-119(+)\]*

[AWK333]{.ul} *pgrn-1(tm985) I; Ex\[Pced-1*::*asp-3*::*mrfp + pRF4(rol-6)\]; unc-119(ed3) III; pwIs50\[Plmp-1*::*lmp-1*::*GFP + Cbr-unc-119(+)\]*

[AWK247]{.ul} *pgrn-1(tm985) I; pwls50\[lmp-1*::*GFP + Cbr-unc-119(+)\];rocEx14 \[Ppgrn-1+SS*::*granulin2*::*FLAG*::*polycis tronic mCherry + Pmyo-2*::*GFP\]*

[AWK334]{.ul} *pgrn-1(tm985) I; Ex\[Pced-1*::*asp-3*::*mrfp + pRF4(rol-6)\]; unc-119(ed3) III; pwIs50\[Plmp-1*::*lmp-1*::*GFP + Cbr-unc-119(+)\]; rocIs5\[Ppgrn-1+SS*::*granulin3*::*FLAG*::*polycis tronic mCherry + Pmyo-2*::*GFP\]*

[AWK177]{.ul} *asp-3(tm4450) X*

[VM487]{.ul} *nmr-1(ak4)II*

Generation of transgenic *C*. *elegans* {#sec012}
---------------------------------------

To generate strains expressing individual granulins, each granulin was amplified separately from wild-type *C*. *elegans* progranulin cDNA as previously described \[[@pgen.1008295.ref039]\].

ER stress assays {#sec013}
----------------

ER stress assays were performed as previously described \[[@pgen.1008295.ref040]\].

Animal viability {#sec014}
----------------

L4 stage animals were allowed to lay eggs overnight. Fifty synchronized eggs were transferred to seeded plates. After three days, the fraction of animals that developed to the L4 stage was quantified.

Body size {#sec015}
---------

L4 animals were staged, grown at 20 °C overnight and imaged the following day as day 1 adults. Animals were mounted on a 2% agarose pad with 25 mM sodium azide (Spectrum Chemical, \#SO110) and imaged using a Zeiss AxioImager microscope at 10 x. Body size was measured in ImageJ software using the skeletonize function.

Short-term associative learning {#sec016}
-------------------------------

Short-term associative learning assays were performed as previously described \[[@pgen.1008295.ref043], [@pgen.1008295.ref044]\].

Immunoblotting {#sec017}
--------------

Sixty L4 stage animals were allowed to lay eggs overnight (\~sixteen hours). Adult worms and hatched larvae were washed off the plates with M9 buffer. Eggs were collected with a cell scraper and transferred to a newly seeded plate by chunking. These eggs were allowed to develop to early L4 stage and 200 μl of 20 mM FUDR (Fisher Scientific, \#AC227601000) was added to prevent development of progeny and overgrowth of plates. At each time point, animals were collected from plates with ice cold M9 and washed once to remove food. The worm pellet was resuspended 1:1 in freshly made ice cold RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% SDS, 0.5% SDO, 1% NP-40, 1 mM PMSF, cOmplete protease inhibitor (Roche, \#[04693124001](http://lifescience.roche.com/shop/en/us/products/complete-3271352-1)) and PhosSTOP phosphatase inhibitor (Roche, \#04906837001), 0.3 mM Pefabloc (Roche, \#11429868001)). Worms were transferred to Eppendorf tubes and sonicated for 4 cycles of 1 minute on and 2 minutes off (BioRuptor, Diagenode). Lysates were centrifuge for 5 minutes at 13,000 rpm at 4 °C. Supernatant was transferred to a fresh Eppendorf tube and samples were boiled at 95 °C (with 4x LDS, 10% reducing agent) for 5 minutes and analyzed by SDS PAGE. 10--50 μg total protein was resolved on 4--12% gradient SDS-PAGE gels and transferred to PVDF.

Antibodies {#sec018}
----------

Commercial antibodies used for Western blotting were the following:

Anti-HSP-4/BiP (Novus Biologicals, \#NBP1-06274, 1:1000 dilution)

Anti-RFP (GenScript, \#A00682, 1:1000 dilution)

Anti-FLAG (Sigma, \#F3165, 1:1000 dilution)

Anti-LMP-1(Developmental Studies Hybridoma Bank, \#LMP1, 1:100 dilution)

Anti-HSP-70/HSC-70 (Santa Cruz Biotechnology Inc., \#sc-33575, 1:1000 dilution)

Anti-calnexin (Novus Biologicals, \#NBP1-97476, 1:1000 dilution)

Anti-CPL-1 (Abcam, \#ab58991, 1:500 dilution)

Anti-actin (EMD Millipore, \#MAB1501R, 1:5000 dilution)

Goat anti-mouse (LI-COR IRDye 800CW, \#925--32210, 1:10,000 dilution)

Goat anti-rabbit (LI-COR IRDye 800CW, \#925--32211, 1:10,000 dilution)

Donkey anti-goat (LI-COR IRDye 800CW, \#925--32214, 1:10,000 dilution)

Donkey anti-mouse (LI-COR IRDye 680RD, \#925--68072, 1:10,000 dilution)

Antibodies made in-house and used for Western blotting were the following:

Anti-granulin 1(RB2481, Biomatik, epitope HQCDAETEC(acm)SDDET, 1:1000 dilution)

Anti-granulin 3 (RB2487, Biomatik, epitope CTVLMVESARSTLKL, 1:1000 dilution)

Anti-ASP-3 (Fred Hutchinson, epitope CTGPTDVIKKIQHKIG, 1:1000 dilution)

Imaging and quantification were performed on the LI-COR Odyssey Infrared System. Three independent blots were performed.

Confocal microscopy {#sec019}
-------------------

Animals were mounted on microscope slides with 2% agarose pads containing 30 mM levamisole hydrochloride (Fisher Scientific, \#AC187870100) and imaged using a Zeiss LSM 700 laser-scanning confocal microscope using 488 nm and 561 nm lasers and 63x and 100x objectives. L1 animals were imaged 1--2 h after hatching. Z-stacks were taken every 0.7 μm. Image processing was carried out using ImageJ software. A maximum intensity projection of the z-stack for each animal was created. Images at 488 nm and 561 nm were overlaid and analyzed for co-localization.

Subcellular fractionation {#sec020}
-------------------------

Thirty L4 stage animals were picked to 60 x 10 cm plates per strain. Plates were confluent with mixed stage animals after four days growth at 20 °C. Progranulin cleavage was observed after starving animals for an additional seventy-two hours at 20 °C. A lysosomal fraction was isolated from a light mitochondrial-lysosomal fraction as previously described \[[@pgen.1008295.ref068]\] with the following modifications. Animals were collected in 0.25 M sucrose (pH 7.2) and washed twice with 0.25 M sucrose. Lysosomes and mitochondria were separated using a discontinuous Nycodenz (Progen Biotechnik, Germany, \#1002424) density gradient. Lysosomes were collected from the 19.8% / sucrose interface and the 26.3 / 19.8% interface and pooled. Lysosomes were diluted five times with 0.25 M sucrose, and pelleted at 37,000 × *g* for 15 minutes. Cytosolic, ER and lysosomal fractions were confirmed by immunoblotting for specific subcellular fraction markers (LAMP-1, HSC-70, calnexin).

Protease activity measurements from total worm lysates {#sec021}
------------------------------------------------------

Protease activity was measured using commercially available kits (BioVision Cathepsin D Activity Fluorometric Assay Kit, \#K143-100 and BioVision Cathepsin L Activity Fluorometric Assay Kit, \#K142-100). Animals were staged as for immunoblotting, but without the addition of 20 mM FUDR. At day 1 of adulthood, worms were collected from plates with ice cold M9 and washed twice to remove food. Worm pellets were resuspended in 1% NP-40 buffer (Fisher Scientific) without protease inhibitors and frozen at -80 °C overnight. Pellets were thawed and sonicated for 4 cycles of 1 min on and 2 min off (BioRuptor, Diagenode). Lysates were centrifuged for 5 minutes at 13,000 rpm at 4 °C and supernatant was transferred to a fresh tube. 0.25 μg total protein per sample was used per assay and samples from one strain were run in triplicate. Fluorescence measurements were taken every minute at 25 °C (Infinite M200, Tecan). As controls, 250 nM Pepstatin A (for pan-aspartyl protease inhibition in CTSD assay, BioVision) or 10 μM CA-074 (for Cathepsin B inhibition, EMD Millipore, \#205530) and 10 μM CTSLiII (for Cathepsin L inhibition, EMD Millipore, \#219426) were added to the lysate and pre-incubated for 10 minutes on the bench at room temperature. Linear regression was performed on at least 30 minutes of data to calculate the rate of enzyme activity.

Computational analysis of granulin domains {#sec022}
------------------------------------------

Sequences for *C*. *elegans* (Q9U362), *Homo sapiens* (P28799) and *Mus musculus* (P28798) PGRN were extracted from Uniprot (The Uniprot Consortium, 2019), while *Danio rerio* PGRNb ([AAH96854.1](https://www.ncbi.nlm.nih.gov/protein/AAH96854.1?report=genbank&log$=protalign&blast_rank=1&RID=EF41E1ES014)) sequence was obtained from National Center for Biotechnology Information (NCBI) Protein database (<https://www.ncbi.nlm.nih.gov>). Amino acid multiple sequence alignment was performed using the MAFFT online service (version 7, <https://mafft.cbrc.jp/alignment/server/>) \[[@pgen.1008295.ref069]\]. The EMBOSS Needle server was used for pairwise sequence alignment between *C*. *elegans* granulin 1, granulin 2 and granulin 3 and individual granulin domains from *H*. *sapiens*, *M*. *musculus and D*. *rerio (*<https://www.ebi.ac.uk/Tools/psa/emboss_needle/>) \[[@pgen.1008295.ref070]\]. Identification of granulin domains from the full-length sequences was based on sequence similarity to *H*. *sapiens* granulin A using the Basic Local Alignment Search Tool protein (BLASTp) server (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>). Granulin A (PDB ID: 2JEY.A) was used as a reference for homology modeling of all granulin domains \[[@pgen.1008295.ref071]\] using the Prime software. Electrostatic analysis ranging from pH 4 to 8 was performed on the *in silico* models with the software propKa 3.1 \[[@pgen.1008295.ref072]\]. Kyte & Doolitle (K&D) hydrophobicity scales were obtained from the ExPASy Bioinformatics Resource Portal (<https://web.expasy.org>) for PGRN sequence of all species here studied. For the K&D per-residue score, a window size of 5 was used, i.e. the final score for a given residue i is the sum of the scale values for i and i-2, i-1, i+1 and i+2.

RNA-sequencing analysis {#sec023}
-----------------------

Total RNA was isolated from wild-type (N2E), *pgrn-1(-)*, *pgrn-1(-)*; granulin 1(+), *pgrn-1(-)*; granulin 2(+) and *pgrn-1(-)*; granulin 3(+) expressing animals synchronized at day 1 of adulthood. Animals were collected from plates with ice cold M9 and washed three times to remove OP50 food. After harvesting, the animals were resuspended in QIAzol (Qiagen \#79306) and flash frozen in liquid nitrogen. RNA was extracted and purified using a Qiagen miRNeasy kit (Qiagen \#217004). Samples were extracted in quadruplicate (four biological replicates for each strain), for a total of 20 samples. Total RNA was quantified using the RiboGreen assay (ThermoFisher, \#R11490) and RNA quality was checked using an Agilent TapeStation 4200 (Agilent). RNA Integrity Numbers (eRINs) were \>8 in all the samples. Libraries for RNA-seq were prepared using the Illumina TruSeq library preparation protocol (Illumina Inc), multiplexed into a single pool and sequenced using an Illumina HiSeq 4000 sequencer across 4 PE 2 x 75 lanes on a single flowcell. After demultiplexing, we obtained between 13 and 32 million reads per sample, each one 75 paired end bases long. Quality control was performed on base qualities and nucleotide composition of sequences. Alignment to the *C*. *elegans* genome (ce11) was performed using the STAR spliced read aligner \[[@pgen.1008295.ref073]\] with default parameters. Additional QC was performed after the alignment to examine the following: level of mismatch rate, mapping rate to the whole genome, repeats, chromosomes, and key transcriptomic regions (exons, introns, UTRs, genes). Between 92 and 93% of the reads mapped uniquely to the worm genome. Total counts of read fragments aligned to candidate gene regions within the *C*. *elegans* reference gene annotation were derived using HTS-seq program and used as a basis for the quantification of gene expression. Only uniquely mapped reads were used for subsequent analyses. Following alignment and read quantification, we performed quality control using a variety of indices, including sample clustering, consistency of replicates, and average gene coverage. One sample for *pgrn-1(-)*; *granulin 1(+)* was excluded from analysis as a quality control outlier. Differential expression analysis was performed using two parallel approaches, the EdgeR Bioconductor package \[[@pgen.1008295.ref074]\], and voom \[[@pgen.1008295.ref075]\]. Differentially expressed genes (DEGs) were selected based on False Discovery Rate (FDR, Benjamini-Hochberg adjusted p-values) estimated at ≤ 5%. There was a large overlap between DEGs identified by edgeR and voom (edgeR: 89.0% common DEGs with voom (6307/7084), voom: 93.9% common DEGs with edgeR (6307/6714)). Clustering and overlap analyses were performed using the Bioconductor packages within the statistical environment R ([www.rproject.org/](http://www.rproject.org/)). Gene Ontology annotation was performed using DAVID (david.abcc.ncifcrf.gov/) and GOrilla \[[@pgen.1008295.ref076], [@pgen.1008295.ref077]\].

TFEB binding site analysis {#sec024}
--------------------------

The promoter regions of all differentially regulated transcripts were analyzed for the presence of the *C*. *elegans* TFEB/HLH-30 binding site E-box sequence 5'-CACGTG-3'. Enrichment of TFEB binding sites was tested by comparison to the expected distribution based on 10,000 random permutations. A permutation test was used to calculate p-values.

HLH-30/TFEB imaging {#sec025}
-------------------

Forty L4 animals were picked, grown at 20 °C overnight and imaged the following day as day 1 adults. The nuclear localization of HLH-30::GFP was imaged using a Zeiss AxioImager microscope at 10x. Animals were imaged within 5 minutes of mounting on a 2% agarose pad with 25mM sodium azide (Spectrum Chemical, \#SO110). Data from three independent experiments were pooled.

Supporting information {#sec026}
======================

###### *C*. *elegans* granulins specifically impair resistance to ER stress.

(**A**) Total worm lysates from synchronized day 1 adult animals over-expressing *C*. *elegans* progranulin (CePGRN-1 OE) were immunoblotted with an anti-granulin 1 antibody after being grown in the presence and absence of 5μg tunicamycin (3 biological replicates, TM = tunicamycin). Anti-HSP-4/BiP, the nematode homolog of human BiP/Grp78, was used to confirm the induction of ER stress and anti-actin was used as a loading control. (**B**) Quantification of HSP-4/BiP expression in the presence and absence of 5μg tunicamycin in *pgrn-1(-)* animals (3 biological replicates, error bars show mean ± SEM). (**C**) Quantification of HSP-4/BiP expression in the presence and absence of 5μg tunicamycin in animals with *C*. *elegans* progranulin over-expression (3 biological replicates, error bars show mean ± SEM). (**D**) Quantification of CePGRN-1 expression in the presence and absence of 5μg tunicamycin in animals with *C*. *elegans* progranulin OE (3 biological replicates, error bars show mean ± SEM). (**E**) Wild-type (N2) and *pgrn-1(-)* animals with and without *C*. *elegans* granulin 2 and progranulin over-expression were subjected to ER stress with tunicamycin (2 μg / ml). The fraction developing to L4 stage was quantified (n = 50, 3 biological replicates). Granulin 1 and 3 could not be tested because these transgenes are on the same chromosome as the progranulin over-expression transgene and recombinants were not obtained from the crosses. (**F**) Wild-type (N2) and *pgrn-1(-)* animals with and without *C*. *elegans* granulin 3, human 1N4R tau and human TDP-43 over-expression were subjected to ER stress with tunicamycin (5 μg / ml). The fraction developing to L4 stage was quantified (n = 50, 3 biological replicates).

(TIF)

###### 

Click here for additional data file.

###### Expressed granulins are found within lysosomes.

(**A-C**) Validation of subcellular fractions from *C*. *elegans* by blotting for fraction-specific markers: (**A**) anti-LMP-1 is specific for the lysosomal fraction, (**B**) anti-HSP-70 which is normally found in both cytosolic and lysosomal fractions, and (**C**) calnexin which localizes to the ER fraction. Similar results were observed in three independent Western blots. WL = whole lysate, C = cytosol, L = lysosomes, ER = endoplasmic reticulum.

(TIF)

###### 

Click here for additional data file.

###### Progranulin expression and cleavage is stress-responsive.

(**A-D**) Quantification of actin-corrected mean band intensities from Western blot of *C*. *elegans* PGRN-1::RFP lysates with (**A-B**) aging, and (**C-D**) starvation. Actin-corrected mean band intensities were normalized to highest value per experiment (data from three biological replicates is shown, values shown are mean ± SEM, one-way ANOVA and Tukey multiple comparisons test, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001). (**E**) In *C*. *elegans pgrn-1(-)*; PGRN-1::RFP lysates the most prominent cleavage product at \~30 kDa was recognized by both granulin 3 and RFP antibodies. (**F**) Subcellular fractionation of *pgrn-1(-)*; PGRN::RFP animals. Whole lysate (WL), cytosol (C), lysosome (L) and endoplasmic reticulum (ER) fractions from starved (70 hours off-food) animals were immunoblotted with anti-RFP and anti-LMP-1 antibodies.

(TIF)

###### 

Click here for additional data file.

###### GO enrichment analysis highlights shared terms between granulin-expression compared to wildtype animals.

(**A**) RNA sequencing read counts at the progranulin gene locus (n = 4). Error bars show the mean ± SEM, one-way ANOVA with post-hoc Tukey multiple comparisons test. (**B**) Numbers of differentially expressed genes (DEGs) identified in the comparisons indicated. (**C-D**) GO term enrichment analysis for *pgrn-1(-)* animals compared to wildtype (WT) for (**C**) Biological Process (BP) and (**D**) Molecular Function (MF) categories. (**E**) GO term enrichment analysis for *pgrn-1(-)*; granulin 1(+) animals compared to WT for BP. (**F-H**) GO term enrichment analysis for *pgrn-1(-)*; granulin 2(+) animals compared to WT for (**F**) BP, (**G**) MF and (**H**) Cellular Component (CC) categories. (**I-K**) GO term enrichment analysis for *pgrn-1(-)*; granulin 3(+) animals compared to WT for (**I**) BP, (**J**) MF and (**K**) CC categories. For all panels, data from four independent biological replicates are shown (except for granulin 1 where one sample was excluded as a quality control outlier). The significance cut-off was a false discovery rate (FDR) of *P*\<0.05, up-regulated = red, down-regulated = green. For C-K, the number of DEGs identified within each GO term is indicated in parentheses.

(TIF)

###### 

Click here for additional data file.

###### GO enrichment analysis highlights shared terms between granulin 2 and 3 expression compared to progranulin null animals.

(**A-C**) GO term enrichment analysis for *pgrn-1(-)*; granulin 2(+) animals compared to *pgrn-1(-)* for (**A**) Biological Process (BP), (**B**) Molecular Function (MF) and (**C**) Cellular Component (CC) categories. (**D-F**) GO term enrichment analysis for *pgrn-1(-)*; granulin 3(+) animals compared to WT for (**D**) BP and (**E**) MF and (**F**) CC categories. For all panels, data from four independent biological replicates are shown. The significance cut-off was a false discovery rate (FDR) of *P*\<0.05, up-regulated = red, down-regulated = green. The number of DEGs identified within each GO term is indicated in parentheses.

(TIF)

###### 

Click here for additional data file.

###### Granulin-induced impairment of development, lysosome morphology and HLH-30/TFEB localization is diminished in the presence of wildtype progranulin.

(**A**) Percentage of animals with nuclear localized HLH-30::GFP (n = 90 animals from 3 biological replicates). Representative images of *pgrn-1(-); tau(+)* and *pgrn-1(-); TDP-43(+)* animals expressing HLH-30::GFP are shown (scale bar = 200 μm). (**B**) Wild-type (N2) and *pgrn-1(-)* animals with and without granulin expression were staged as embryos. Animals were scored for development to L4 stage (n = 50, 3 biological replicates). (**C**) Representative light and fluorescent confocal images of anterior coelomocyte cells expressing LMP-1::GFP in N2; granulin 2(+) and N2; granulin 3(+) animals. Scale bars are 10 μm. Dashed white lines mark the outline of each coelomocyte cell. (**D**) Lysosomal diameter measurements from anterior coelomocyte cells (n = 60). Mean values (μm): wt: 1.57 ± 0.04, *pgrn-1(-)*: 1.37 ± 0.05, N2; granulin 2(+): 1.62 ± 0.04, *pgrn-1(-)*; granulin2(+): 1.47 ± 0.05, N2; granulin 3(+): 1.23 ± 0.03, *pgrn-1(-)*; granulin3(+): 1.16 ± 0.05. (**E**) Percentage of animals with nuclear localized HLH-30::GFP (n = 120 animals from 4 biological replicates). (**F**) Wild-type (N2) and *pgrn-1(-)* animals with and without granulin expression were subjected to ER stress with tunicamycin (5 μg / ml). The fraction developing to L4 stage was quantified (n = 50, 3 biological replicates). For panels A, B, C, E and F, error bars show the mean ± SEM, one-way ANOVA with post-hoc Tukey multiple comparisons test. Comparisons are to wildtype unless otherwise indicated (\**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001, wt = wildtype, ns = not significant).

(TIF)

###### 

Click here for additional data file.

###### Identification of enriched GO terms on progranulin loss and granulin expression through edgeR and DAVID analysis.

(See corresponding Excel file).

(XLSX)

###### 

Click here for additional data file.

###### Identification of enriched GO terms on progranulin loss and granulin expression through edgeR and GOrilla analysis.

(See corresponding Excel file).

(XLSX)

###### 

Click here for additional data file.

###### Identification of enriched GO terms on progranulin loss and granulin expression through voom and DAVID analysis.

(See corresponding Excel file).

(XLSX)

###### 

Click here for additional data file.

###### Identification of enriched GO terms on progranulin loss and granulin expression through voom and GOrilla analysis.

(See corresponding Excel file).

(XLSX)

###### 

Click here for additional data file.

###### Identification of TFEB binding sites in differentially regulated transcripts from progranulin loss and granulin expression.

(See corresponding Excel file).

(XLSX)

###### 

Click here for additional data file.
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